Heterogeneity of human adipose blood flow.
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 1, doi. 10.1186/1472-6904-7-1
- Publication type:
- Article
Works matching IS 14726904 AND DT 2007 AND VI 7
Results: 14
1
2
Aspects of statin prescribing in Norwegian counties with high,average and low statin consumption--an individual-levelprescription database study.
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 14, doi. 10.1186/1472-6904-7-14
- By:
- Publication type:
- Article
3
Expression of thymidine phosphorylase in peripheral blood cells of breast cancer patients is not increased by paclitaxel.
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 7, doi. 10.1186/1472-6904-7-7
- By:
- Publication type:
- Article
4
Antimalarial activity of the anticancer and proteasome inhibitorbortezomib and its analog ZL<sub>3</sub>B.
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 13, doi. 10.1186/1472-6904-7-13
- By:
- Publication type:
- Article
5
Pharmacokinetics, safety and efficacy from randomized controlledtrials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell®).
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 11, doi. 10.1186/1472-6904-7-11
- By:
- Publication type:
- Article
6
Pharmacokinetics of recombinant human growth hormone administered by cool.click™2, a new needle-free device, compared with subcutaneous administration using a conventional syringe and needle.
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 10, doi. 10.1186/1472-6904-7-10
- By:
- Publication type:
- Article
7
Trends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998-2005.
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 9, doi. 10.1186/1472-6904-7-9
- By:
- Publication type:
- Article
8
Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study.
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 8, doi. 10.1186/1472-6904-7-8
- By:
- Publication type:
- Article
9
Influence of an e-mail with a drug information attachment on salesof prescribed drugs: a randomized controlled study.
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 12, doi. 10.1186/1472-6904-7-12
- By:
- Publication type:
- Article
10
Phenotype-genotype analysis of CYP2C19 in Colombian mestizo individuals.
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 6, doi. 10.1186/1472-6904-7-6
- By:
- Publication type:
- Article
11
Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls.
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 5, doi. 10.1186/1472-6904-7-5
- By:
- Publication type:
- Article
12
Does atenolol differ from other β-adrenergic blockers?
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 4, doi. 10.1186/1472-6904-7-4
- By:
- Publication type:
- Article
13
Pharmacokinetic investigation of dose proportionality with a 24-hour controlled-release formulation of hydromorphone.
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 3, doi. 10.1186/1472-6904-7-3
- By:
- Publication type:
- Article
14
Pharmacokinetic profile of a 24-hour controlled-release OROS formulation of hydromorphone in the presence and absence of food.
- Published in:
- BMC Clinical Pharmacology, 2007, v. 7, p. 1, doi. 10.1186/1472-6904-7-2
- By:
- Publication type:
- Article